NurExone Biologic Inc. (TSXV:NRX)
Canada
· Delayed Price · Currency is CAD 0.600
-0.020 (-3.23%)
At close: Mar 9, 2026
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 54.45 million as of March 9, 2026. Its market cap has increased by 18.46% in one year.
Market Cap
54.45M
Enterprise Value
53.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 54.45M, an increase of 62.62%. That is a compound annual growth rate of 14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 56.27M | -5.99% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 54.63M |
| Sharp Therapeutics | 67.67M |
| Medicenna Therapeutics | 68.40M |
| MedMira | 45.33M |
| ME Therapeutics Holdings | 75.12M |
| Resverlogix | 39.49M |
| BriaCell Therapeutics | 37.49M |
| Defence Therapeutics | 35.57M |